LY03020: Clinical Trials

1 trial of LY03020, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow LY03020: new trials by email Literature Review of LY03020 trials Research Report on LY03020

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
LY03020, Placebo - Schizophrenia
Phase 2Not yet recruitingLuye Pharma Group Ltd.1602026-03-312026-02-09

Conditions studied

Schizophrenia (1)

Sponsors

Luye Pharma Group Ltd. (1)

Countries

China (1)